Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative randomized double blind controlled trial of antiemetic effect between single daily dose versus divided dose intravenous ondansetron in pediatric cancer patients
TCTR20190812002Phase 3Completed
- Sponsor
- Phramongkutklao Hospital and College of Medicine
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ondansetron in chemotherapy-induced nausea and vomiting (CINV), childhood cancer, sponsored by Phramongkutklao Hospital and College of Medicine. Started Aug 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)childhood cancer
Beyond the preview
Go deeper on TCTR20190812002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190812002.